Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma
Clinical trial NCT04083066 · UNKNOWN
Trial details
- NCT number
- NCT04083066
- Sponsor
- Mingzhi Zhang
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2023-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.